Ameriprise’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.64M | Buy |
62,835
+2,327
| +4% | +$320K | ﹤0.01% | 1918 |
|
|
2025
Q1 | $10.9M | Sell |
60,508
-52,968
| -47% | -$9.55M | ﹤0.01% | 1699 |
|
|
2024
Q4 | $17.8M | Buy |
113,476
+23,727
| +26% | +$3.72M | ﹤0.01% | 1401 |
|
|
2024
Q3 | $16.3M | Sell |
89,749
-12,247
| -12% | -$2.23M | ﹤0.01% | 1445 |
|
|
2024
Q2 | $18.7M | Buy |
101,996
+58,605
| +135% | +$10.8M | 0.01% | 1325 |
|
|
2024
Q1 | $7.72M | Buy |
43,391
+27,452
| +172% | +$4.88M | ﹤0.01% | 2020 |
|
|
2023
Q4 | $1.98M | Buy |
15,939
+3,960
| +33% | +$491K | ﹤0.01% | 2880 |
|
|
2023
Q3 | $1.39M | Buy |
+11,979
| New | +$1.39M | ﹤0.01% | 2998 |
|
|
2020
Q3 | – | Sell |
-28,806
| Closed | -$1.19M | – | 3757 |
|
|
2020
Q2 | $1.19M | Buy |
28,806
+12,996
| +82% | +$538K | ﹤0.01% | 2851 |
|
|
2020
Q1 | $684K | Buy |
+15,810
| New | +$684K | ﹤0.01% | 2986 |
|